This paper presents real-life decisions involved in the integrated approach to drug development, covering the early development journey of a small molecule from formulation through clinical supply.
From Formulation to Clinic
Connecting drug substance, drug product and supply reduces handoffs.
Operational Decisions
Examples show how trade-offs between speed, cost and risk are made in practice.
Benefits of Integration
Shared data and a single accountable partner accelerate timelines.
About This White Paper
This white paper is published by Catalent and curated by Biotechnology Media Insights, a trusted source for pharmaceutical and biotechnology research, technical guides and industry analysis.